Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,033 | -2,877 | -1,306 | -5,352 | -4,159 |
| Accounts receivable | -770 | -485 | -91 | -1,747 | -1,349 |
| Other Working Capital | 1,224 | 840 | 82 | -1,398 | -947 |
| Other Operating Activity | 1,495 | 960 | 318 | 3,039 | 2,237 |
| Operating Cash Flow | $-2,085 | $-1,563 | $-998 | $-5,459 | $-4,219 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 64 | 25 | 25 | 14,742 | 11,245 |
| Other Financing Activity | 0 | 0 | 0 | -426 | -426 |
| Financing Cash Flow | $64 | $25 | $25 | $14,316 | $10,818 |
| Beginning Cash Position | 13,597 | 13,597 | 13,597 | 4,739 | 4,739 |
| End Cash Position | 11,576 | 12,059 | 12,624 | 13,597 | 11,339 |
| Net Cash Flow | $-2,021 | $-1,538 | $-973 | $8,857 | $6,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,085 | -1,563 | -998 | -5,459 | -4,219 |
| Free Cash Flow | -2,085 | -1,563 | -998 | -5,459 | -4,219 |